ST8814_Par_TNO_107_2_hg38_intergenic_count.txt

syn63658364

Created By Alyza Skaist askaist

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

ST8814_Par_TNO_107_2_hg38_intergenic_count.txt page is loading…